Legislative Research: US HB7839 | 2019-2020 | 116th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 118th Congress (Introduced) | To amend the Better Utilization of Investments Leading to Development Act 2018 to prioritize support to projects under that Act that increase digital infrastructure and connectivity. [HB7839 2023 Detail][HB7839 2023 Text][HB7839 2023 Comments] | 2024-03-29 Referred to the House Committee on Foreign Affairs. |
| 2021-2022 117th Congress (Introduced - Dead) | To prevent conflicts of interest and promote competition in the sale and purchase of digital advertising. [HB7839 2021 Detail][HB7839 2021 Text][HB7839 2021 Comments] | 2022-11-01 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
| 2019-2020 116th Congress (Introduced - Dead) | Extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are... [HB7839 2019 Detail][HB7839 2019 Text][HB7839 2019 Comments] | 2020-07-29 Referred to the Subcommittee on Health. |
References Online
Legislative Citation
APA
US HB7839 | 2019-2020 | 116th Congress. (2020, July 29). LegiScan. Retrieved April 29, 2024, from https://legiscan.com/US/bill/HB7839/2019
MLA
"US HB7839 | 2019-2020 | 116th Congress." LegiScan. LegiScan LLC, 29 Jul. 2020. Web. 29 Apr. 2024. <https://legiscan.com/US/bill/HB7839/2019>.
Chicago
"US HB7839 | 2019-2020 | 116th Congress." July 29, 2020 LegiScan. Accessed April 29, 2024. https://legiscan.com/US/bill/HB7839/2019.
Turabian
LegiScan. US HB7839 | 2019-2020 | 116th Congress. 29 July 2020. https://legiscan.com/US/bill/HB7839/2019 (accessed April 29, 2024).
Subjects
Congressional oversight
Drug therapy
Government studies and investigations
Health
Health programs administration and funding
Health technology, devices, supplies
Hereditary and development disorders
Home and outpatient care
Immunology and vaccination
Medicare
Drug therapy
Government studies and investigations
Health
Health programs administration and funding
Health technology, devices, supplies
Hereditary and development disorders
Home and outpatient care
Immunology and vaccination
Medicare
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/7839/all-info |
| Text | https://www.congress.gov/116/bills/hr7839/BILLS-116hr7839ih.pdf |
